Expert capital advisory solutions for pharmaceutical and drug companies.
Pharmaceutical & Biopharma M&A
Maximizing seller value in mergers & acquisitions
Tell us about your M&A needs
Our M&A Process
Mergers & Acquisitions Advisory
for the middle market.
Assess Financial Readiness
Align M&A Criteria
Research Target Industry
Target List Building
Letter of Intent (LOI)
Pharmaceuticals Investment Bank
MERGERS & ACQUISITIONS ADVISORY
FOR THE MIDDLE MARKET
Our team provides specialized capital advisory and investment banking solutions to pharmaceutical and biotechnology companies across the middle market. Our pharmaceutical team assists clients across a number of key niches including over-the-counter products and services, drug discovery and development, generic drugs, biosimilar, nutraceuticals, medical technology and agricultural biotechnology.
By providing strategic and holistic analysis and deal processing tools, we assist our clients in complete value maximization across the value chain from growth financing to mergers and acquisitions. Our expert network of experienced deal makers understands the strict regulatory hurdles involved in the manufacturing and marketing of medical pharmaceuticals. This subject matter expertise, combined with a detailed understanding of both investors and players in the field, creates a quality solution for clients looking for the right investment bank in pharmaceuticals.
Because no deal or project is exactly alike, our pharmaceutical and biotech teams tailor client engagements to match the short and long term goals of our client’s businesses.